BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 736614)

  • 1. Urinary delta-aminolevulinic acid as a biological indicator throughout penicillamine therapy in lead intoxication.
    Molina-Ballesteros G; Zuñiga-Charles MA; Sanchez-Anzaldo FJ; Gonzalez-Ramirez JD
    Arch Environ Health; 1978; 33(6):308-13. PubMed ID: 736614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of urinary hemoglobin and delta-aminolevulinic acid in adults males exposed to lead (author's transl)].
    Molina Ballesteros G; Zúñiga-Charles MA; Sánchez-Anzaldo FJ
    Rev Invest Clin; 1979; 31(3):245-9. PubMed ID: 523859
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mobilization of lead in patients with chronic poisoning by that metal. Oral penicillamine].
    González-Ramírez D; Zuñiga-Charles M; Narro-Juárez A
    Arch Invest Med (Mex); 1990; 21(3):279-83. PubMed ID: 2131778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of urinary delta-aminolevulinic acid as an index of lead exposure by high-performance liquid chromatography.
    Ogata M; Taguchi T
    Ind Health; 1986; 24(4):259-64. PubMed ID: 3818368
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of delta aminolevulinic acid in urine in a population exposed to lead].
    Molina-Ballesteros G; Zuñiga-Charles MA; Sanchez-Anzaldo FJ
    Arch Invest Med (Mex); 1976; 7(3):115-22. PubMed ID: 1015930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental lead intoxication in dogs: a comparison of blood lead and urinary delta-aminolevulinic acid following intoxication and chelation therapy.
    Green RA; Selby LA; Zumwalt RW
    Can J Comp Med; 1978 Apr; 42(2):205-13. PubMed ID: 667707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorimetric determination of urinary delta-aminolevulinic acid by high-performance liquid chromatography and post-column derivatization.
    Okayama A
    J Chromatogr; 1988 Apr; 426(2):365-9. PubMed ID: 3392148
    [No Abstract]   [Full Text] [Related]  

  • 8. [Improved method for the determination of urinary delta-aminolevulinic acid in lead workers].
    Tomokuni K; Hasegawa N; Sugawara E
    Sangyo Igaku; 1986 Mar; 28(2):114-8. PubMed ID: 3761711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of concentrations of gamma aminolevulinic acid and creatinine in the urine (screening test for lead exposure by urinary spot samples)].
    Kikuchi M; Nishima T
    Nihon Eiseigaku Zasshi; 1975 Apr; 30(1):108. PubMed ID: 1169457
    [No Abstract]   [Full Text] [Related]  

  • 10. [Circadian rhythms in urinary coproporphyrin and delta-aminolevulinic acid].
    Sanguinetti F; Dompé M; Mantovani S
    Ann Ist Super Sanita; 1978; 14(3):601-5. PubMed ID: 755411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of the urinary excretion of delta-aminolevulinic acid as a criterion for lead absorption in industrial medicine and insurance medicine.
    Lahaye D; Roosels D; Bossiroy JM; van Assche F
    Int Arch Occup Environ Health; 1977 Aug; 39(3):191-8. PubMed ID: 924689
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renal delta-aminolevulinic acid excretion in persons not exposed to lead].
    Massmann W
    Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie; 1982 Jun; 32(6):210-2. PubMed ID: 7113496
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimized liquid-chromatographic method for fluorometric determination of urinary delta-aminolevulinic acid in workers exposed to lead.
    Tomokuni K; Ichiba M; Hirai Y; Hasegawa T
    Clin Chem; 1987 Sep; 33(9):1665-7. PubMed ID: 3621570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of urinary delta-aminolevulinic acid determination in the evaluation of individual exposure to lead].
    Sartor F; Rondia D
    Arch Belg Med Soc; 1978 May; 36(5):283-95. PubMed ID: 736553
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urine concentration of delta ALA in children: an indicator of lead contamination in Santiago (author's transl)].
    Cisternas R; Sáez M
    Rev Chil Pediatr; 1980; 51(1):13-8. PubMed ID: 7422942
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison between the fluorometric HPLC method and the conventional method for determining urinary delta-aminolevulinic acid and coproporphyrin as indices of lead exposure.
    Tomokuni K; Ichiba M; Hirai Y; Sugimoto K; Yoshida T; Hirata M
    Int Arch Occup Environ Health; 1988; 61(3):153-6. PubMed ID: 3220586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood lead, urinary delta aminolevulinic acid and the diagnosis of lead poisoning in dogs.
    Canfield PJ; Fairburn AJ; Watson AD
    Aust Vet J; 1984 Oct; 61(10):323-4. PubMed ID: 6525118
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversible forms of motor neuron disease. Lead "neuritis".
    Boothby JA; DeJesus PV; Rowland LP
    Arch Neurol; 1974 Jul; 31(1):18-23. PubMed ID: 4834538
    [No Abstract]   [Full Text] [Related]  

  • 19. Urine delta-aminolevulinic acid and erythropoietic activity in human lead intoxication.
    Canberk A; Sehirli I; Canberk Y; Koyuncuoŏglu H
    Toxicol Appl Pharmacol; 1978 May; 44(2):257-61. PubMed ID: 675700
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronobiological study of the urinary excretion of delta-aminolevulinic acid in man].
    Botta A; Bruguerolle B; Bartolin R; Bouvenot G
    Rev Med Interne; 1986 Sep; 7(4):421-4. PubMed ID: 3797874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.